Fenofibrate Impurities - SZEB
Time:2023-05-06
Views:170
Fenofibrate is FDA approved to treat patients with hypertriglyceridemia, primary hypercholesterolemia, or mixed dyslipidemia. It reduces low-density lipoprotein cholesterol (LDL-C), total cholesterol, triglycerides, and apolipoprotein B and increases high-density lipoprotein cholesterol (HDL-C) in adults.
To support your analysis and help ensure the accuracy of quality processes, we supply a range of Fenofibrate -related impurities standards with certified COA and characterization data like Mass, HPLC, NMR & TGA report.
The following are some of the impurities of Fenofibrate :
.jpg)
Wechat
Jolin
Yuzhu Lin
Ciel Wong
whatsapp